122 related articles for article (PubMed ID: 6751178)
1. The efficacy of isoproterenol inhalation for predicting the response to orally administered theophylline in chronic obstructive pulmonary disease.
Dull WL; Alexander MR; Sadoul P; Woolson RF
Am Rev Respir Dis; 1982 Oct; 126(4):656-9. PubMed ID: 6751178
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study.
Alexander MR; Dull WL; Kasik JE
JAMA; 1980 Nov; 244(20):2286-90. PubMed ID: 7001056
[TBL] [Abstract][Full Text] [Related]
3. Theophylline in stable chronic airflow obstruction. A reappraisal.
Dull WL; Alexander MR
Arch Intern Med; 1984 Dec; 144(12):2399-401. PubMed ID: 6391407
[TBL] [Abstract][Full Text] [Related]
4. Isoproterenol challenge during placebo and oral theophylline therapy in chronic obstructive pulmonary disease.
Dull WL; Alexander MR; Kasik JE
Am Rev Respir Dis; 1981 Mar; 123(3):340-2. PubMed ID: 7224346
[TBL] [Abstract][Full Text] [Related]
5. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.
Thomas P; Pugsley JA; Stewart JH
Chest; 1992 Jan; 101(1):160-5. PubMed ID: 1729064
[TBL] [Abstract][Full Text] [Related]
6. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction.
Taylor DR; Buick B; Kinney C; Lowry RC; McDevitt DG
Am Rev Respir Dis; 1985 May; 131(5):747-51. PubMed ID: 4003919
[TBL] [Abstract][Full Text] [Related]
8. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
Dai L; Li X; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.
Murciano D; Auclair MH; Pariente R; Aubier M
N Engl J Med; 1989 Jun; 320(23):1521-5. PubMed ID: 2498658
[TBL] [Abstract][Full Text] [Related]
10. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
[TBL] [Abstract][Full Text] [Related]
11. [Theophylline treatment of irreversible, chronic obstructive pulmonary disease].
Iversen ET; Eiken PA; Nielsen LM; Laursen LC; Maltbaek N; Tønnesen FV; Rasmussen FV
Ugeskr Laeger; 1994 Sep; 156(39):5696-9. PubMed ID: 7985256
[TBL] [Abstract][Full Text] [Related]
12. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
13. Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study.
Li JS; Li SY; Yu XQ; Xie Y; Wang MH; Li ZG; Zhang NZ; Shao SJ; Zhang YJ; Zhu L; Guo LX; Bai YP; Wang YF
J Ethnopharmacol; 2012 Jun; 141(2):584-91. PubMed ID: 21911051
[TBL] [Abstract][Full Text] [Related]
14. Clinical comparison of albuterol, isoetharine, and metaproterenol given by aerosol inhalation.
Berezuk GP; Schondelmeyer SW; Seidenfeld JJ; Jones WN; Bootman JL
Clin Pharm; 1983; 2(2):129-34. PubMed ID: 6349905
[TBL] [Abstract][Full Text] [Related]
15. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
[TBL] [Abstract][Full Text] [Related]
16. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
Chrystyn H; Mulley BA; Peake MD
BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
[TBL] [Abstract][Full Text] [Related]
17. The effect of maintenance theophylline therapy on lung work in severe chronic obstructive pulmonary disease while standing and walking.
Jenne JW; Siever JR; Druz WS; Solano JV; Cohen SM; Sharp JT
Am Rev Respir Dis; 1984 Oct; 130(4):600-5. PubMed ID: 6486559
[TBL] [Abstract][Full Text] [Related]
18. Effect of inhaled atropine or metaproterenol in patients with chronic airway obstruction and therapeutic serum theophylline levels.
Passamonte PM; Martinez AJ
Chest; 1984 May; 85(5):610-5. PubMed ID: 6370619
[TBL] [Abstract][Full Text] [Related]
19. Bronchodilator response in chronic obstructive pulmonary disease.
Anthonisen NR; Wright EC
Am Rev Respir Dis; 1986 May; 133(5):814-9. PubMed ID: 3706890
[TBL] [Abstract][Full Text] [Related]
20. Effect of theophylline in chronic obstructive lung disease.
Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
